EV/EBITDA
-10.12
+0.02+0.20%
52 min ago
Summary
- As of March 3, 2025, APGE EV/EBITDA is -10.12, with a rise of +0.02 (+0.20%) during the most recent trading day.
- Over the past year, APGE EV/EBITDA has increased by +1.95 (+16.16%).
- APGE EV/EBITDA is now -27.46% below its all-time high of -7.94.
Performance
APGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.2% | -0.1% | -0.1% |
| 1 m1 month | +22.0% | -22.0% | -21.0% |
| 3 m3 months | +32.3% | -32.3% | -31.0% |
| 6 m6 months | +44.1% | -29.9% | -34.0% |
| ytdytd | +30.8% | -30.8% | -29.5% |
| 1 y1 year | +16.2% | +29.3% | -14.2% |
| 5 y5 years | - | - | - |
APGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.9% | -13.68 | +26.0% | |
| 3 m | 3-month | -9.65 | -4.9% | -16.88 | +40.0% |
| 6 m | 6-month | -9.65 | -4.9% | -22.64 | +55.3% |
| 1 y | 1-year | -9.65 | -4.9% | -32.16 | +68.5% |
| 3 y | 3-year | -7.94 | -27.5% | -32.16 | +68.5% |
| 5 y | 5-year | -7.94 | -27.5% | -32.16 | +68.5% |
| alltime | all time | -7.94 | -27.5% | -32.16 | +68.5% |
Apogee Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -10.12(-30.8%) |
| Date | Value |
|---|---|
| 2024 | -14.62(-0.7%) |
| 2023 | -14.72 |
FAQ
- What is Apogee Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Apogee Therapeutics?
- What is APGE EV/EBITDA year-to-date change?
- What is Apogee Therapeutics EV/EBITDA year-on-year change?
What is Apogee Therapeutics EV/EBITDA?
The current EV/EBITDA of APGE is -10.12
What is the all time high EV/EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high EV/EBITDA is -7.94
What is APGE EV/EBITDA year-to-date change?
Apogee Therapeutics EV/EBITDA has changed by +4.50 (+30.78%) since the beginning of the year
What is Apogee Therapeutics EV/EBITDA year-on-year change?
Over the past year, APGE EV/EBITDA has changed by +1.95 (+16.16%)